1-11 of 11
Luqun Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study

Luqun Wang, Wei Yang, Ting Niu, Yafei Wang, Rong Fu, Yuping Zhong, Kaiyang Ding, Kai Sun, Baijun Fang, Hong Liu, Wenbin Qian, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7874.
https://doi.org/10.1182/blood-2024-201134
Published: 2024
Journal Articles

Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd

Lu Zhang, Qinhua Liu, Hui Zhou, Huilai Zhang, Yujun Dong, Xiaobo Wang, Luqun Wang, Liping Su, Xiaojing Yan, Yan Li, Mingzhi Zhang, Kaiyang Ding, Hui-Han Wang, Hongling Peng, Liye Zhong, Lin Yang, Lintao Bi, Da Gao, Guangxun Gao, Liang Huang, Chunyan Sun, Jia Song, Wenbin Qian, Wenrong Huang, Zhenling Li, Yao Liu, Jian Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 4417.
https://doi.org/10.1182/blood-2024-204513
Published: 2024
Journal Articles

Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma：a Multicenter Real-World Study

Na Liu, Luqun WANG, Rentong Liu, Yuping Zhong, Xianqi Feng, Zhongliang Sun, Jie Li, Fanjun Meng, Junjie MA, Changyong Yuan, Hao Li, Ling Wang, Zhilong Xu, Jie Yu, Hao Zhang, Chen Chunyan
Journal: Blood
Blood (2023) 142 (Supplement 1): 6632.
https://doi.org/10.1182/blood-2023-179687
Published: 2023
Journal Articles

Efficacy of Daratumumab in 34 Patients with Newly Diagnosed Multiple Myeloma in Real World Study

Xiangxin Li, Lingling Wang, Fanglin Li, Hai Zhou, Na Liu, Shuang Yu, Qi Feng, Hao Li, Luqun Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6680.
https://doi.org/10.1182/blood-2023-182649
Published: 2023
Journal Articles

Real-World Analysis of Treatment Patterns and the Effectiveness and Safety Profile of Daratumumab-Based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/Refractory Multiple Myeloma

Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6635.
https://doi.org/10.1182/blood-2023-180948
Published: 2023
Journal Articles

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide (CPCT) for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Multicenter Phase II Trial

Wei Xu, Jin-Hua Liang, Li Wang, Xiao-Dong Wang, Guohui Cui, Jianfeng Zhou, Jingyan Xu, Luqun Wang, Rong Liang, Bi-yun Chen, Jian Cheng, Jian-Yong Li
Journal: Blood
Blood (2022) 140 (Supplement 1): 9484–9486.
https://doi.org/10.1182/blood-2022-157014
Published: 2022
Journal Articles

Oligosecretory Waldenström Macroglobulinemia Patients Exhibit Excellent Treatment Response and Outcomes

Ying Yu, Wenjie Xiong, Zanzan Wang, Yuting Yan, Jiawen Chen, Yanshan Huang, Xinxin Cao, Zhongxing Jiang, Huihan Wang, Zhen Cai, Juan Du, Chunyan Sun, Ting Niu, Guangzhong Yang, Hua Xue, Bingzong Li, Honghui Huang, Zhenling Li, Qinhua Liu, Fei Li, Ou Bai, Min Mao, Rong Fu, Ling Wang, Chunrui Li, Xiaoxia Chu, Lihong Liu, Yujun Dong, Luqun Wang, Jun Luo, Yongqiang Wei, Lugui Qiu, Jian Li, ShuHua Yi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9289–9291.
https://doi.org/10.1182/blood-2022-157311
Published: 2022
Journal Articles

Waldenström's Macroglobulinaemia in the Modern Era: Real World Outcomes and Prognostication across 35 Chinese Academic Hospitals

Xin-xin Cao, MD, Shuhua Yi, MD, Zhongxing Jiang, MD, Jingsong He, MD, Wei Yang, Juan Du, Jr., MD, Chunyan Sun, MD PhD, Yu Wu, MD, Chen Wenming, MD, Xiao-jun Liu, Bingzong Li, MDPhD, Chunrui Li, MDPhD, Wei Sang, Qin-hua Liu, Xiaoxia Chu, Li Fei, Ou Bai, Min Mao, Rong Fu, PhD, Wei WANG, MD, Lihong Liu, MD, Luqun Wang, MDPhD, Yujun Dong, MD, Jun Luo, DO, Zhenling Li, Yongqiang Wei, Qi-ke Zhang, Jing Liu, Kaiyang Ding, Liang Zou, Bi-yun Chen, Luoming Hua, PhD, Hongmei Jing, Juan He, PhD, Liang Wang, Lugui Qiu, MD, Jian Li, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-134785
Published: 2020
Journal Articles

Comprehensive Geriatric Assessment in Consecutive Newly-Diagnosed Elderly Multiple Myeloma Patients in China: A Multicentered, Prospective, Non-Interventional Study

Yuan Yao, Dehui Zou, Aijun Liao, Xiaoxia Chu, Wei Wang, Xinan Cen, Lijuan Chen, MD PhD, Li Bao, Rong Fu, Jr., PhD, Hui Liu, Chunyan Sun, MD PhD, Luqun Wang, MD, Fengyan Jin, MD PhD, Hua Yan, Chenglu Yuan, Liangming Ma, Guangxun Gao, Jinqiao Zhang, MD, Da Gao, MD, Jianda Hu, PhD, Jianxia He, Ai-lin Zhao, Lu Zhang, MD, Dao-Bin Zhou, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5493.
https://doi.org/10.1182/blood-2019-125447
Published: 2019
Journal Articles

Bortezomib: Once-Weekly 1.6mg/m 2 Maybe a Better Choice Compared with Twice-Weekly 1.3mg/m 2 in Newly Dignosed Multiple Myeloma

Yubin Li, Fangfang Li, Wangshan Song, Zhumei Zhan, Xiangxin Li, Lingling Wang, Fanglin Li, MD, Ming Hou, MD PhD, Hao Li, MD, Luqun Wang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5558.
https://doi.org/10.1182/blood-2019-125714
Published: 2019
Journal Articles

The Establishment of Bortezomib Resistant Myeloma Cell Line KM3/BTZ and Explore the Resistance Mechanism

Luqun Wang, Qiong Liu, Hao Li, Li Lizhen, Xin Wang
Journal: Blood
Blood (2014) 124 (21): 5226.
https://doi.org/10.1182/blood.V124.21.5226.5226
Published: 2014